Shachar Shlosberger
Vermogen: 19 412 $ op 31-07-2026
Vermogen: 19 412 $ op 31-07-2026
Shachar Shlosberger is currently the Chief Financial Officer at Enlivex Therapeutics Ltd. She previously worked as the Finance Director at Prolor Biotech Ltd. Shlosberger holds a Master's in Business Administration from The College of Management Academic Studies.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ENLIVEX LTD. 0,06% | 18-03-2026 | 9.288 ( 0,06% ) | 19 412 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ENLIVEX | Financieel Directeur/CFO | 01-01-2016 |
| Bedrijven | Functie | Einde |
|---|---|---|
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
The College of Management Academic Studies
The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau